FDA Removes REMS Requirements for BCMA- and CD19-Targeted CAR-T Therapies
Policy / Regulatory

FDA Removes REMS Requirements for BCMA- and CD19-Targeted CAR-T Therapies

ProFound Therapeutics and Novartis Forge Four-Year Partnership for Cardiovascular Drug Targets
CompanyDeals

ProFound Therapeutics and Novartis Forge Four-Year Partnership for Cardiovascular Drug Targets

Diagens Biotech's AI Imaging Platform iMedImage Makes Hong Kong IPO Debut
CompanyDeals

Diagens Biotech’s AI Imaging Platform iMedImage Makes Hong Kong IPO Debut

Pfizer's Emblaveo Approved by China's NMPA for Complex Infections
CompanyDrug

Pfizer’s Emblaveo Approved by China’s NMPA for Complex Infections

Gilead's Lenacapavir Approved in Hainan for HIV-1 Pre-Exposure Prophylaxis
CompanyDrug

Gilead’s Lenacapavir Approved in Hainan for HIV-1 Pre-Exposure Prophylaxis

GenFleet Therapeutics Files for Hong Kong IPO Amid KRAS Inhibitor Success
CompanyDeals

GenFleet Therapeutics Files for Hong Kong IPO Amid KRAS Inhibitor Success

DK Medtech Partners with Mozarc Medical to Enhance Hemodialysis Access Solutions
CompanyDeals

DK Medtech Partners with Mozarc Medical to Enhance Hemodialysis Access Solutions

ACIP Recommends MSD's Enflonsia for Infants Under 8 Months to Prevent RSV
CompanyDrug

ACIP Recommends MSD’s Enflonsia for Infants Under 8 Months to Prevent RSV

Viatris Announces Positive Results in VEGA-3 Trial for MR-141 Presbyopia Treatment
Others

Viatris Announces Positive Results in VEGA-3 Trial for MR-141 Presbyopia Treatment

Jenscare's LuX-Valve Plus Shows Promising Results in Global TRINITY Study
CompanyMedical Device

Jenscare’s LuX-Valve Plus Shows Promising Results in Global TRINITY Study

Innovent Biologics' Mazdutide Gets NMPA Nod for Weight Management
CompanyDrug

Innovent Biologics’ Mazdutide Gets NMPA Nod for Weight Management

Mabwell Bioscience Partners With Calico Life Sciences on 9MW3811 Development
CompanyDeals

Mabwell Bioscience Partners With Calico Life Sciences on 9MW3811 Development